Physician
Lifespan of Massachusetts - Fall River INC
Lifespan of Massachusetts - Fall River INC was paid $905K by Medicaid between Oct 2024 and Dec 2024, across 119 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoLIFESPAN OF MASSACHUSETTS - FALL RIVER INC
FALL RIVER, MA 02721
FALL RIVER, MA 02721
33aNPI1972330165assigned 09/19/2024
33bProvider typeHematology & Oncology Physician
28Total paid$905K
24GClaims12,641
24DCodes billed119
24AFirst – last monthOct 2024 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Massachusetts
Rank by total paid#1 of 25
Median peer was paid$6K
This provider vs. median143×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 12,641 | $905K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 754 | 719 | $140K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12% | 790 | 728 | $106K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 412 | 380 | $94K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 466 | 452 | $93K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 8.2% | 48 | 47 | $74K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.5% | 120 | 102 | $59K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 6.0% | 36 | 36 | $55K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.3% | 38 | 37 | $30K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 116 | 115 | $21K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.8% | 99 | 35 | $16K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.7% | 15 | 14 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 92 | 92 | $15K |
107 more codes
| 87428 | 1.5% | 241 | $14K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 79 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 91 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 73 | $13K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 61 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 428 | $10K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 123 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 265 | $9K |
| 62323 | <1% | 12 | $8K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 28 | $6K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 32 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 738 | $5K |
| ATP14 | <1% | 365 | $4K | |
| 12001 | <1% | 12 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 18 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 18 | $4K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 14 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 41 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 61 | $3K |
| 76770 | <1% | 12 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 14 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $2K |
| ATP08 | <1% | 212 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 279 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 124 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $2K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12 | $2K |
| 84484 | <1% | 221 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 41 | $1K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 81 | $1K |
| 81025 | <1% | 178 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 358 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 43 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 43 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 108 | $1K |
| 73610 | <1% | 46 | $958.88 | |
| 97802 | <1% | 14 | $932.71 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 13 | $880.84 |
| 84703 | <1% | 144 | $861.90 | |
| 83690 | <1% | 146 | $845.12 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 26 | $775.97 |
| 93270 | <1% | 20 | $775.00 | |
| 97161 | <1% | 12 | $767.31 | |
| 82728 | <1% | 62 | $745.24 | |
| 90715 | <1% | 32 | $736.50 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 104 | $704.88 |
| 73130 | <1% | 43 | $663.84 | |
| 84466 | <1% | 59 | $663.75 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 16 | $659.30 |
| 76830 | Ultrasound, transvaginal | <1% | 19 | $659.30 |
| G0378 | Hospital observation service, per hour | <1% | 22 | $650.31 |
| 87081 | <1% | 100 | $555.75 | |
| ATP15 | <1% | 51 | $544.32 | |
| 72100 | <1% | 13 | $534.76 | |
| 81001 | <1% | 196 | $504.00 | |
| 73630 | <1% | 33 | $479.44 | |
| 83735 | <1% | 79 | $390.06 | |
| 87807 | <1% | 34 | $381.15 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $371.28 |
| 83540 | <1% | 59 | $342.60 | |
| 86850 | <1% | 38 | $310.32 | |
| J2704 | Injection, propofol, 10 mg | <1% | 271 | $290.62 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 174 | $290.62 |
| 81003 | <1% | 161 | $279.18 | |
| 87070 | <1% | 31 | $243.20 | |
| 82947 | <1% | 160 | $242.90 | |
| 85730 | <1% | 45 | $238.50 | |
| 87077 | <1% | 31 | $199.64 | |
| 84702 | <1% | 15 | $199.05 | |
| 85610 | <1% | 52 | $192.78 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 32 | $187.40 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 14 | $186.60 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 172 | $172.01 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 92 | $153.49 |
| 73140 | <1% | 13 | $147.52 | |
| 73562 | <1% | 13 | $147.52 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 194 | $145.31 |
| 86900 | <1% | 39 | $97.68 | |
| 86901 | <1% | 39 | $97.68 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34 | $96.40 |
| 73030 | <1% | 22 | $92.20 | |
| 87186 | <1% | 13 | $91.56 | |
| 73110 | <1% | 12 | $73.76 | |
| 83615 | <1% | 42 | $15.99 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 14 | $3.33 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 20 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 63 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 265 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 139 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 66 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 26 | $0.00 |
| 80076 | 0% | 22 | $0.00 | |
| 84100 | 0% | 15 | $0.00 | |
| 80143 | 0% | 15 | $0.00 | |
| 80179 | 0% | 13 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 21 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 280 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 437 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 72 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 184 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 192 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 41 | $0.00 |
| 96376 | 0% | 25 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 96 | $0.00 |
| 80320 | 0% | 13 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 30 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREENWOOD, EVA (SVP, FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Lifespan of Massachusetts - Taunton INC | Taunton, MA | $375K |
| The Miriam Hospital | Providence, RI | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.